203 related articles for article (PubMed ID: 29654048)
1. The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System.
Pratt NL; Kerr M; Barratt JD; Kemp-Casey A; Kalisch Ellett LM; Ramsay E; Roughead EE
BMJ Open; 2018 Apr; 8(4):e021122. PubMed ID: 29654048
[TBL] [Abstract][Full Text] [Related]
2. Validity of medication-based co-morbidity indices in the Australian elderly population.
Vitry A; Wong SA; Roughead EE; Ramsay E; Barratt J
Aust N Z J Public Health; 2009 Apr; 33(2):126-30. PubMed ID: 19413854
[TBL] [Abstract][Full Text] [Related]
3. The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure.
Pugh MJ; Marcum ZA; Copeland LA; Mortensen EM; Zeber JE; Noël PH; Berlowitz DR; Downs JR; Good CB; Alvarez C; Amuan ME; Hanlon JT
Drugs Aging; 2013 Aug; 30(8):645-54. PubMed ID: 23645530
[TBL] [Abstract][Full Text] [Related]
4. Adapting the Rx-Risk-V for mortality prediction in outpatient populations.
Johnson ML; El-Serag HB; Tran TT; Hartman C; Richardson P; Abraham NS
Med Care; 2006 Aug; 44(8):793-7. PubMed ID: 16862043
[TBL] [Abstract][Full Text] [Related]
5. Classifying Multimorbidity Using Drug Concepts via the Rx-Risk Comorbidity Index: Methods and Comparative Cross-Sectional Study.
Vanderbleek JJ; Owensby JK; McAnnally A; England BR; Chen L; Curtis JR; Yun H
Arthritis Care Res (Hoboken); 2024 Apr; 76(4):559-569. PubMed ID: 37986017
[TBL] [Abstract][Full Text] [Related]
6. Contribution of an extensive medication-based comorbidity index (Rx-Risk) in explaining the excess mortality after hip fracture in older Norwegians: a NOREPOS cohort study.
Holvik K; Hjellvik V; Karlstad Ø; Gunnes N; Hoff M; Tell GS; Meyer HE
BMJ Open; 2022 May; 12(5):e057823. PubMed ID: 35501100
[TBL] [Abstract][Full Text] [Related]
7. Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 - 2018.
Vesterager JD; Madsen M; Hjelholt TJ; Kristensen PK; Pedersen AB
Clin Epidemiol; 2022; 14():275-287. PubMed ID: 35299726
[TBL] [Abstract][Full Text] [Related]
8. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting.
Lu CY; Barratt J; Vitry A; Roughead E
J Clin Epidemiol; 2011 Feb; 64(2):223-8. PubMed ID: 21172602
[TBL] [Abstract][Full Text] [Related]
9. Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study.
Vitry AI; Roughead EE; Preiss AK; Ryan P; Ramsay EN; Gilbert AL; Caughey GE; Shakib S; Esterman A; Zhang Y; McDermott RA
PLoS One; 2010 Nov; 5(11):e14024. PubMed ID: 21103337
[TBL] [Abstract][Full Text] [Related]
10. Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.
Tiruye T; Roder D; FitzGerald LM; O'Callaghan M; Moretti K; Beckmann K
Cancer Epidemiol; 2024 Feb; 88():102516. PubMed ID: 38141473
[TBL] [Abstract][Full Text] [Related]
11. Correction:
BMJ Open; 2020 Sep; 10(9):e021122corr1. PubMed ID: 32895287
[No Abstract] [Full Text] [Related]
12. Automated computerized intensive care unit severity of illness measure in the Department of Veterans Affairs: preliminary results. SISVistA Investigators. Scrutiny of ICU Severity Veterans Health Sysyems Technology Architecture.
Render ML; Welsh DE; Kollef M; Lott JH; Hui S; Weinberger M; Tsevat J; Hayward RA; Hofer TP
Crit Care Med; 2000 Oct; 28(10):3540-6. PubMed ID: 11057814
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pharmacy-based and diagnosis-based comorbidity measures from medical administrative data.
Cortaredona S; Pambrun E; Verdoux H; Verger P
Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):402-411. PubMed ID: 27910177
[TBL] [Abstract][Full Text] [Related]
14. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.
Daskivich TJ; Kwan L; Dash A; Greenfield S; Litwin MS
Eur Urol; 2014 Dec; 66(6):1002-9. PubMed ID: 24924554
[TBL] [Abstract][Full Text] [Related]
15. Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients.
Johnston JA; Wagner DP; Timmons S; Welsh D; Tsevat J; Render ML
Med Care; 2002 Oct; 40(10):929-40. PubMed ID: 12395026
[TBL] [Abstract][Full Text] [Related]
16. A disease-specific comorbidity index for predicting mortality in patients admitted to hospital with a cardiac condition.
Azzalini L; Chabot-Blanchet M; Southern DA; Nozza A; Wilton SB; Graham MM; Gravel GM; Bluteau JP; Rouleau JL; Guertin MC; Jolicoeur EM
CMAJ; 2019 Mar; 191(11):E299-E307. PubMed ID: 30885968
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database.
Dong YH; Chang CH; Shau WY; Kuo RN; Lai MS; Chan KA
Pharmacotherapy; 2013 Feb; 33(2):126-36. PubMed ID: 23386595
[TBL] [Abstract][Full Text] [Related]
18. Effect of external variables on the performance of the geriatric comorbidity score derived from prescription claims in the community-dwelling elderly.
Béland SG; Tannenbaum C; Ducruet T; Préville M; Berbiche D; Moride Y
Drugs Aging; 2012 Nov; 29(11):891-7. PubMed ID: 23109256
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data.
Lund JL; Kuo TM; Brookhart MA; Meyer AM; Dalton AF; Kistler CE; Wheeler SB; Lewis CL
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):584-592. PubMed ID: 30891850
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants.
Caughey GE; Roughead EE; Shakib S; McDermott RA; Vitry AI; Gilbert AL
Age Ageing; 2010 Jul; 39(4):488-94. PubMed ID: 20511245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
